Radiolabelled tyrosine for the measurement of protein synthesis rate in vivo by positron emission tomography

被引:12
|
作者
Paans, AMJ
Pruim, J
VanWaarde, A
Willemsen, ATM
Vaalburg, W
机构
[1] PET Center, Groningen University Hospital, 9700 RB Groningen
来源
关键词
D O I
10.1016/S0950-351X(96)80666-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The amino acid incorporation rate, generally described as protein synthesis rate or PSR, can be assessed in vivo using carboxylic-labelled amino acids such as L-[1-11C]tyrosine and PET. In animals, labelled tissue metabolites are below 4% of total tissue radioactivity and are therefore neglected in the model. Labelled plasma metabolites on the other hand rise continuously to 50% of total plasma radioactivity at 40 minutes. After correction of the total plasma radioactivity for the metabolite fraction, a Patlak analysis may be performed to calculate the PSR. A number of applications in the field of oncology were presented. The use of L-[1-11C]tyrosine in the study of metabolic disease was also discussed. It is concluded that the application of [11C]tyrosine-PET in a clinical setting is of interest for an increasing number of diseases.
引用
收藏
页码:497 / 510
页数:14
相关论文
共 50 条
  • [1] Positron emission tomography in oncology - In vivo measurement of protein synthesis in tumors
    Paans, AMJ
    Pruim, J
    Van Waarde, A
    Willemsen, ATM
    Vaalburg, W
    [J]. POSITRON EMISSION TOMOGRAPHY: CRITICAL ASSESSMENT OF RECENT TRENDS, 1998, 51 : 185 - 198
  • [2] Tyrosine positron emission tomography and protein synthesis rate in pituitary adenoma: Different effects of surgery and radiation therapy
    van den Bergh, Alfons C. M.
    Pruim, Jan
    Links, Thera P.
    van der Vliet, Anton M.
    Sluiter, Wim
    Wolffenbuttel, Bruce H. R.
    Langendijk, Johannes A.
    Hoving, Eelco W.
    Dullaart, Robin P. F.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2011, 98 (02) : 213 - 216
  • [3] Pharmacokinetics of radiolabelled anticancer drugs for positron emission tomography
    Hutchinson, OC
    Collingridge, DR
    Barthel, H
    Price, PM
    Aboagye, EO
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2003, 9 (11) : 917 - 929
  • [4] Pharmacodynamics of radiolabelled anticancer drugs for positron emission tomography
    Hutchinson, OC
    Collingridge, DR
    Barthel, H
    Price, PM
    Aboagye, EO
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2003, 9 (11) : 931 - 944
  • [5] Radiolabelled Peptides for Positron Emission Tomography and Endoradiotherapy in Oncology
    Rangger, Christine
    Haubner, Roland
    [J]. PHARMACEUTICALS, 2020, 13 (02)
  • [6] Visualisation and assessment of the protein synthesis rate of lung cancer using carbon-11 tyrosine and positron emission tomography
    Pieterman, R
    Willemsen, A
    Appel, M
    Pruim, J
    Koëter, G
    Vaalburg, W
    Groen, H
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2002, 29 (02) : 243 - 247
  • [7] Visualisation and assessment of the protein synthesis rate of lung cancer using carbon-11 tyrosine and positron emission tomography
    Remge Pieterman
    Antoon Willemsen
    Milo Appel
    Jan Pruim
    Gerard Koëter
    Willem Vaalburg
    Harry Groen
    [J]. European Journal of Nuclear Medicine and Molecular Imaging, 2002, 29 : 243 - 247
  • [8] Radiolabelled Molecules for Imaging the Translocator Protein (18 kDa) Using Positron Emission Tomography
    Dolle, Frederic
    Luus, Christopher
    Reynolds, Aaron
    Kassiou, Michael
    [J]. CURRENT MEDICINAL CHEMISTRY, 2009, 16 (22) : 2899 - 2923
  • [9] Measurement of protein flux with positron emission tomography in neonates
    Nama, V
    Kozlowski, JK
    Hamvas, A
    [J]. ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION, 1999, 80 (01): : F26 - F29
  • [10] L-(1-C-11)TYROSINE FOR THE MEASUREMENT OF PROTEIN-SYNTHESIS IN TUMOR AND BRAIN WITH POSITRON EMISSION TOMOGRAPHY
    VAALBURG, W
    ISHIWATA, K
    ELSINGA, PH
    PAANS, AMJ
    WOLDRING, MG
    [J]. JOURNAL OF NUCLEAR MEDICINE, 1986, 27 (06) : 1049 - 1049